0001014108-24-000040.txt : 20240906 0001014108-24-000040.hdr.sgml : 20240906 20240906092817 ACCESSION NUMBER: 0001014108-24-000040 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240906 DATE AS OF CHANGE: 20240906 EFFECTIVENESS DATE: 20240906 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bond Biosciences, Inc. CENTRAL INDEX KEY: 0001824224 ORGANIZATION NAME: IRS NUMBER: 810933527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-523360 FILM NUMBER: 241283113 BUSINESS ADDRESS: STREET 1: 555 MADISON AVENUE STREET 2: SUITE 1201 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 650-804-2139 MAIL ADDRESS: STREET 1: 555 MADISON AVENUE STREET 2: SUITE 1201 CITY: NEW YORK STATE: NY ZIP: 10022 D 1 primary_doc.xml X0708 D LIVE 0001824224 Bond Biosciences, Inc. 170 English Landing Drive Suite 201B Parkville MO MISSOURI 64152 650-804-2139 DELAWARE Fetterex Biopharma, Inc. None Corporation true Michael A. Riley 170 English Landing Drive Suite 201B Parkville MO MISSOURI 64152 Executive Officer Director Cory Berkland 170 English Landing Drive Suite 201B Parkville MO MISSOURI 64152 Executive Officer Director Timothy Opler 170 English Landing Drive Suite 201B Parkville MO MISSOURI 64152 Director Michael Beckloff 170 English Landing Drive Suite 201B Parkville MO MISSOURI 64152 Director Other Health Care Decline to Disclose 06b false 2024-08-22 false true Simple Agreement for Future Equity false 0 Collage Venture Partners, LLC 316063 Stonehaven, LLC 118913 929 Alton Road Suite 500 Miami Beach FL FLORIDA 33139 AL ALABAMA CA CALIFORNIA CO COLORADO FL FLORIDA GA GEORGIA IL ILLINOIS IN INDIANA KS KANSAS ME MAINE MD MARYLAND MO MISSOURI NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA TN TENNESSEE TX TEXAS UT UTAH WI WISCONSIN false 4500000 2630000 1870000 false 51 184100 0 0 false Bond Biosciences, Inc. /s/Michael A. Riley Michael A. Riley Chief Executive Officer 2024-09-05